K
Klaus Seppi
Researcher at Innsbruck Medical University
Publications - 366
Citations - 25650
Klaus Seppi is an academic researcher from Innsbruck Medical University. The author has contributed to research in topics: Parkinsonism & Medicine. The author has an hindex of 74, co-authored 317 publications receiving 20534 citations. Previous affiliations of Klaus Seppi include University of Innsbruck.
Papers
More filters
Journal ArticleDOI
Trial of Deferiprone in Parkinson's Disease.
David Devos,Julien Labreuche,Olivier Rascol,Jean-Christophe Corvol,Alain Duhamel,Pauline Guyon Delannoy,Werner Poewe,Yaroslau Compta,Nicola Pavese,Evžen Růžička,Petr Dusek,Bart Post,Bastiaan R. Bloem,Daniela Berg,Walter Maetzler,Markus Otto,Marie-Odile Habert,Stéphane Lehéricy,Joaquim J. Ferreira,Richard Dodel,Christine Tranchant,Alexandre Eusebio,Stéphane Thobois,A. R. Marques,Wassilios G. Meissner,Fabienne Ory-Magne,Uwe Walter,Rob M.A. de Bie,Miguel Franco Gago,Dolores Vilas,Jaime Kulisevsky,Cristina Januário,Miguel Coelho,Stefanie Behnke,PF Worth,Klaus Seppi,Thavarak Ouk,Camille Potey,C Leclercq,Romain Viard,Grégory Kuchcinski,Renaud Lopes,Jean-Pierre Pruvo,Pascal Pigny,Guillaume Garçon,Ophélie Simonin,Jessica Carpentier,Anne-Sophie Rolland,Dag Nyholm,Christoph Scherfler,Jean-François Mangin,Marie Chupin,Régis Bordet,D. Dexter,Caroline Fradette,Michael Spino,Fernando Tricta,Scott Ayton,Ashley I. Bush,Jean-Christophe Devedjian,James A. Duce,Z. Ioav Cabantchik,Luc Defebvre,Dominique Deplanque,Caroline Moreau +64 more
TL;DR: In this paper , deferiprone was associated with worse scores in measures of parkinsonism than those with placebo over a period of 36 weeks, while brain iron content decreased more in the deferrediprone group than in the placebo group.
Journal ArticleDOI
Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues.
Joseph Classen,Jiri Koschel,Christian Oehlwein,Klaus Seppi,Peter Urban,Christian Winkler,Ullrich Wüllner,Alexander Storch +7 more
TL;DR: Major issues related to NMF are summarized including clinical phenomenology and pathophysiology, and a number of open issues and topics for future research are outlined.
Journal ArticleDOI
Is transcranial sonography useful to distinguish drug-induced parkinsonism from Parkinson's disease?
Philipp Mahlknecht,Heike Stockner,Stefan Kiechl,Johann Willeit,Verena Rastner,Arno Gasperi,Gregor Rungger,Werner Poewe,Klaus Seppi +8 more
TL;DR: The results suggest that TCS might offer an easyto-use, cost-effective aid in the distinction between PD and DIP, and larger, prospective studies are needed to validate its role.
Journal ArticleDOI
The Unified Multiple System Atrophy Rating Scale: Intrarater reliability
Florian Krismer,Klaus Seppi,François Tison,Cristina Sampaio,Anja Zangerl,Cecilia Peralta,Farid Yekhlef,Imad Ghorayeb,Fabienne Ory-Magne,Monique Galitzky,Maria Bozi,Tommaso Scaravilli,Carlo Colosimo,Felix Geser,Felix Geser,Olivier Rascol,Werner Poewe,Niall Quinn,Gregor K. Wenning +18 more
TL;DR: The intrarater agreement of the motor examination part of the UMSARS was determined and provided a surrogate measure of disease progression in multiple system atrophy.
Journal ArticleDOI
Krankheitskosten und Versorgungssituation bei Morbus Parkinson - eine Analyse in Österreich
Sonja von Campenhausen,Yaroslav Winter,Julia Gasser,Klaus Seppi,JP Reese,Karl-P. Pfeiffer,Sabine Geiger-Gritsch,Kai Bötzel,Uwe Siebert,Wolfgang H. Oertel,Richard Dodel,Werner Poewe +11 more
TL;DR: PD is an economic challenge for the Austrian healthcare system and patients bear considerable costs by personal contribution according to the national healthcare system.